Publications by authors named "Delia Cangini"

Claim this Profile
R
Radiopsy: a prospective observational study on quantitative multiparametric whole-body magnetic resonance imaging to discriminate between smoldering and multiple myeloma.
Giacomo Feliciani, Emiliano Loi, Elena Amadori, Eleonora Antognoni, Andrea Prochowski Iamurri, Delia Cangini

Haematologica· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax durable response in adult relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia with pathway alterations.
Anna Ferrari, Delia Cangini, Andrea Ghelli Luserna di Rorà, Annalisa Condorelli, Marta Pugliese

Front Cell Dev Biol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CPX-351 daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia.
Alessandro Cafaro, Maria B Giannini, Paolo Silimbani, Delia Cangini, Carla Masini

Minerva Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tagraxofusp and anti-CD123 in blastic plasmacytoid dendritic cell neoplasm: a new hope.
Delia Cangini, Paolo Silimbani, Alessandro Cafaro, Maria B Giannini, Carla Masini

Minerva Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemtuzumab ozogamicin in acute myeloid leukemia: past, present and future.
Michele Gottardi, Alessandra Sperotto, Andrea Ghelli Luserna Di Rorà, Antonella Padella, Delia Cangini

Minerva Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial.
Claudio Cerchione, Giovanni Martinelli, Marco Picardi, Novella Pugliese, Davide Nappi, Delia Cangini

J Clin Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pentoxifylline-Induced Apoptosis in Chronic Lymphocytic Leukemia: New Insights into Molecular Mechanism.
Roberta Napolitano, Serena De Matteis, Alessandro Lucchesi, Silvia Carloni, Delia Cangini

Mini Rev Med Chem· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia.
Gerardo Musuraca, Serena De Matteis, Roberta Napolitano, Cristina Papayannidis, Viviana Guadagnuolo, Delia Cangini

J Transl Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute oxaliplatin-induced thrombotic thrombocytopenic purpura: a case report and results from a cytoflourimetric assay of platelet fibrinogen receptor.
Alessandro Lucchesi, Silvia Carloni, Delia Cangini, Giovanni Luca Frassineti, Andrea Casadei Gardini

J Clin Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged 18FDG-PET negative complete remission in a heavily pretreated, elderly patient with diffuse large B cell lymphoma treated with lenalidomide, low dose dexamethasone, and colony stimulating factor (Rd-G).
Gerardo Musuraca, Pier Paolo Fattori, Michela Ceccolini, Delia Cangini, Maria Benedetta Giannini

Am J Hematol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible, PET-positive, generalized lymphadenopathy and splenomegaly during high-dose interferon-alpha-2b adjuvant therapy for melanoma.
Laura Ridolfi, Delia Cangini, Riccardo Galassi, Alessandro Passardi, Annamaria Marzullo

J Immunother· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study.
Michele Cavo, Patrizia Tosi, Elena Zamagni, Claudia Cellini, Paola Tacchetti, Delia Cangini

J Clin Oncol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.
Elena Zamagni, Cristina Nanni, Francesca Patriarca, Emanuela Englaro, Paolo Castellucci, Delia Cangini

Haematologica· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone.
Patrizia Tosi, Elena Zamagni, Delia Cangini, Paola Tacchetti, Francesco Di Raimondo

Blood· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete remission upon bortezomib-dexamethasone therapy in three heavily pretreated multiple myeloma patients relapsing after allogeneic stem cell transplantation.
Patrizia Tosi, Elena Zamagni, Delia Cangini, Paola Tacchetti, Giulia Perrone

Ann Hematol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.
Cristina Nanni, Elena Zamagni, Mohsen Farsad, Paolo Castellucci, Patrizia Tosi, Delia Cangini

Eur J Nucl Med Mol Imaging· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
Patrizia Tosi, Elena Zamagni, Claudia Cellini, Raffaele Parente, Delia Cangini

Eur J Haematol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission.
Michele Cavo, Carolina Terragna, Matteo Renzulli, Elena Zamagni, Patrizia Tosi, Delia Cangini

J Clin Oncol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma.
Michele Cavo, Elena Zamagni, Patrizia Tosi, Paola Tacchetti, Claudia Cellini, Delia Cangini

Blood· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma.
Patrizia Tosi, Elena Zamagni, Claudia Cellini, Rosaria Plasmati, Delia Cangini

Eur J Haematol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure.
Patrizia Tosi, Elena Zamagni, Claudia Cellini, Delia Cangini, Paola Tacchetti

Eur J Haematol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma.
Michele Cavo, Elena Zamagni, Patrizia Tosi, Claudia Cellini, Delia Cangini

Haematologica· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation.
Simona Soverini, Michele Cavo, Claudia Cellini, Carolina Terragna, Elena Zamagni, Delia Cangini

Blood· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy.
Michele Cavo, Elena Zamagni, Claudia Cellini, Patrizia Tosi, Delia Cangini

Blood· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma.
Patrizia Tosi, Elena Zamagni, Claudia Cellini, Sonia Ronconi, Francesca Patriarca, Delia Cangini

Haematologica· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis